Abel Bermudez
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
-
- Extracellular vesicles in disease
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
- Glycosylation and Glycoproteins Research
- RNA modifications and cancer
Papers in
-
- Cancer Research and Treatments 4
- Co-authors
- Sharon J. PitteriFernando Jose Garcia-MarquesSanjiv S. GambhirRamasamy PaulmuruganRajendran JC BoseTarik F. MassoudUday Kumar SukumarYitian Zeng
- Journals
- Cancer Research (5 papers)iScience (2 papers)Scientific Reports (2 papers)ACS Nano (2 papers)Journal of Visualized Experiments (2 papers)
- Partner nations
- United StatesMoroccoTaiwan
In The Last Decade
Abel Bermudez
24 papers receiving 791 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 171
- Molecular Biology 612
- Physiology 27
- Immunology 86
- Aging 7
Countries citing papers authored by Abel Bermudez
This map shows the geographic impact of Abel Bermudez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abel Bermudez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abel Bermudez more than expected).
Fields of papers citing papers by Abel Bermudez
This network shows the impact of papers produced by Abel Bermudez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abel Bermudez. The network helps show where Abel Bermudez may publish in the future.
Co-authors
The 25 scholars most cited alongside Abel Bermudez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 8 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 10 | |
| 11 | 2023 | 7 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 19 | |
| 14 | 2021 | 40 | |
| 15 | 2021 | 34 | |
| 16 | 2020 | 65 | |
| 17 | 2020 | 41 | |
| 18 | 2018 | 189 | |
| 19 | 2017 | 58 | |
| 20 | 2017 | 191 |
About Abel Bermudez
Abel Bermudez is a scholar working on Biotechnology, Cancer Research, Molecular Biology, Oncology and Otorhinolaryngology, having authored 32 papers that have together received 797 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Prostate Cancer Treatment and Research (5 papers), Glycosylation and Glycoproteins Research (4 papers), Peptidase Inhibition and Analysis (4 papers), Cancer Research and Treatments (4 papers), CRISPR and Genetic Engineering (3 papers), Genomics and Chromatin Dynamics (3 papers) and Extracellular vesicles in disease (3 papers). The work is most often cited by research in Cancer Research (171 citations), Molecular Biology (612 citations), Physiology (27 citations), Immunology (86 citations) and Aging (7 citations). Abel Bermudez has collaborated with scholars based in United States, Morocco and Taiwan. Frequent co-authors include Sharon J. Pitteri, Fernando Jose Garcia-Marques, Sanjiv S. Gambhir, Ramasamy Paulmurugan, Rajendran JC Bose, Tarik F. Massoud, Uday Kumar Sukumar, Yitian Zeng, Frezghi Habte and Elise Robinson. Their work appears in journals such as Cancer Research, iScience, Scientific Reports, ACS Nano and Journal of Visualized Experiments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.